Sarepta Therapeutics Shows Financial Growth in 2024

TipRanks17minutes ago

Express News | Sarepta Therapeutics Inc : Leerink Partners Cuts Target Price to $210 From $220

Breakings27minutes ago

Sarepta Therapeutics (SRPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Yahoo Finance07:30

Sarepta Therapeutics: Q3 Earnings Snapshot

Yahoo Finance05:22

Earnings Flash (SRPT) SAREPTA THERAPEUTICS Posts Q3 Revenue $467.2M

MT Newswires05:20

Sarepta Therapeutics | 10-Q: Q3 2024 Earnings Report

SEC05:09 · Announcements